{"id":"NCT00761631","sponsor":"Pfizer","briefTitle":"Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years","officialTitle":"A Phase 3, Open Label Trial Evaluating the Safety,Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Aged 15 Months to 17 Years in the United States","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2008-09-29","resultsPosted":"2011-08-10","lastUpdate":"2013-07-31"},"enrollment":1200,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Healthy Subjects"],"interventions":[{"type":"BIOLOGICAL","name":"13 valent pneumococcal conjugate vaccine","otherNames":[]}],"arms":[{"label":"Single","type":"EXPERIMENTAL"}],"summary":"This open-label, multicenter study is designed to evaluate the safety, tolerability and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy children aged more than 15 months up to less than 18 years.","primaryOutcome":{"measure":"Percentage of Participants Achieving Predefined Serotype-specific Immunoglobulin G (IgG) Antibody Concentration Greater Than or Equal to (â‰¥) 0.35 Micrograms Per Milliliter (Mcg/mL) Measured 1 Month After Vaccination in Group 1 and 2","timeFrame":"28 to 42 days after dose 2 for Group 1 and 28 to 42 days after dose 1 for Group 2","effectByArm":[{"arm":"13vPnC Group 1 (Cohort 1)","deltaMin":98.2,"sd":null},{"arm":"13vPnC Group 2 (Cohort 1)","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":["24136369","21983216"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6096A1-3011&StudyName=Study%20Evaluating%2013-valent%20Pneumococcal%20Conjugate%20Vaccine%20%2813vPnC%29%20in%20Healthy%20Children%20Aged%2015%20months%20to%2017%20Years"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":124},"commonTop":["Tenderness (any)","Irritability","Redness (any)","Decreased appetite","Swelling (any)"]}}